Previous Close | 54.07 |
Open | 53.58 |
Bid | 50.90 |
Ask | 55.00 |
Strike | 580.00 |
Expire Date | 2024-11-15 |
Day's Range | 53.58 - 54.07 |
Contract Range | N/A |
Volume | |
Open Interest | 82 |
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
In the most recent trading session, McKesson (MCK) closed at $603.24, indicating a +0.05% shift from the previous trading day.
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients improved treatment options for prostate cancer.